Her scientific interests lie mostly in Cancer research, Genetics, Germline mutation, Mutation and Birt–Hogg–Dubé syndrome. Her research integrates issues of Cancer, Endocrinology, Kidney, DNA methylation and PBRM1 in her study of Cancer research. As part of one scientific family, Laura S. Schmidt deals mainly with the area of Kidney, narrowing it down to issues related to the Carcinoma, and often Loss of heterozygosity and Renal cell carcinoma.
Her Germline mutation research integrates issues from Genome, Aneuploidy and Germline. The study incorporates disciplines such as Respiratory disease, Folliculin and Pathology in addition to Birt–Hogg–Dubé syndrome. Her studies in Clear cell renal cell carcinoma integrate themes in fields like SETD2, Chromatin, microRNA, CDKN2A and Signal transduction.
Laura S. Schmidt mainly investigates Cancer research, Folliculin, Pathology, Genetics and Cancer. Her study in Cancer research is interdisciplinary in nature, drawing from both Mutation, Germline mutation, Kidney cancer, Tumor suppressor gene and Kidney. Her studies deal with areas such as Molecular biology, AMPK, Birt–Hogg–Dubé syndrome, Cell biology and PI3K/AKT/mTOR pathway as well as Folliculin.
The Pathology study combines topics in areas such as Lung and Hereditary leiomyomatosis and renal cell carcinoma. Her study on Cancer also encompasses disciplines like
Her primary areas of investigation include Cancer research, Renal cell carcinoma, Folliculin, Transcription factor and Gene. Her Cancer research research is multidisciplinary, incorporating perspectives in Mutation, Germline mutation, Carcinogenesis, Kidney cancer and TFE3. Laura S. Schmidt has included themes like Cell, BAP1, Kidney and Cancer genome in her Renal cell carcinoma study.
Her Folliculin study combines topics in areas such as Tumor suppressor gene, GTPase and Birt–Hogg–Dubé syndrome. The concepts of her Transcription factor study are interwoven with issues in microRNA and Cell biology. Her work deals with themes such as Transforming growth factor beta and Signal transduction, which intersect with Gene.
Laura S. Schmidt mainly focuses on Cancer research, microRNA, Gene, Renal cell carcinoma and Germline mutation. Her Cancer research study combines topics from a wide range of disciplines, such as Transcription factor, Oncogene, Chromatin, Birt–Hogg–Dubé syndrome and Folliculin. Laura S. Schmidt works mostly in the field of microRNA, limiting it down to topics relating to DNA methylation and, in certain cases, HMGA2, Mutation rate, Signal transduction and Transforming growth factor beta, as a part of the same area of interest.
Her work in the fields of Gene, such as Missense mutation, intersects with other areas such as Characterization and Statistical analysis. Her Renal cell carcinoma research incorporates elements of Cell, BAP1, Computational biology and Cancer genome. Part of her project on Germline mutation includes research on Genetics and Mutation.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Comprehensivemolecular characterization of clear cell renal cell carcinoma
Chad J. Creighton;Margaret Morgan;Preethi H. Gunaratne;Preethi H. Gunaratne;David A. Wheeler.
Mutations of the VHL tumour suppressor gene in renal carcinoma
J.R. Gnarra;K. Tory;Y. Weng;L. Schmidt.
Nature Genetics (1994)
The Molecular Taxonomy of Primary Prostate Cancer
Adam Abeshouse;Jaeil Ahn;Rehan Akbani;Adrian Ally.
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.
Katherine A. Hoadley;Christina Yau;Christina Yau;Toshinori Hinoue;Denise M. Wolf.
Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dubé syndrome.
Michael L. Nickerson;Michelle B. Warren;Jorge R. Toro;Vera Matrosova.
Cancer Cell (2002)
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma.
W. Marston Linehan;Paul T. Spellman;Christopher J. Ricketts;Chad J. Creighton.
The New England Journal of Medicine (2016)
The genetic basis of kidney cancer: a metabolic disease
W. Marston Linehan;Ramaprasad Srinivasan;Laura S. Schmidt.
Nature Reviews Urology (2010)
The Somatic Genomic Landscape of Chromophobe Renal Cell Carcinoma
Caleb F. Davis;Christopher J. Ricketts;Min Wang;Lixing Yang.
Cancer Cell (2014)
Germline mutations in the Von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan.
Berton Zbar;Takeshi Kishida;Fan Chen;Laura Schmidt.
Human Mutation (1996)
Novel mutations of the MET proto-oncogene in papillary renal carcinomas.
L. Schmidt;K. Junker;N. Nakaigawa;T. Kinjerski.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: